Advertisement
UK markets open in 7 hours 13 minutes
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • CRUDE OIL

    79.23
    +0.24 (+0.30%)
     
  • GOLD FUTURES

    2,316.50
    -5.80 (-0.25%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • Bitcoin GBP

    48,871.07
    -1,142.26 (-2.28%)
     
  • CMC Crypto 200

    1,299.40
    +4.73 (+0.37%)
     
  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

HealthStream First Quarter 2024 Earnings: Beats Expectations

HealthStream (NASDAQ:HSTM) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$72.8m (up 5.5% from 1Q 2023).

  • Net income: US$5.23m (up 99% from 1Q 2023).

  • Profit margin: 7.2% (up from 3.8% in 1Q 2023). The increase in margin was driven by higher revenue.

  • EPS: US$0.17 (up from US$0.086 in 1Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

HealthStream Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) also surpassed analyst estimates by 52%.

Looking ahead, revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Healthcare Services industry in the US.

ADVERTISEMENT

Performance of the American Healthcare Services industry.

The company's shares are up 8.0% from a week ago.

Risk Analysis

We should say that we've discovered 1 warning sign for HealthStream that you should be aware of before investing here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.